Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 7, 2015Insights into ImagingOpen Access

Revisiting the risks of MRI with Gadolinium based contrast agents—review of literature and guidelines

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAurangzaib KhawajaQueen Elizabeth Hospital BirminghamDCDeirdre CassidyTexas Medical CenterJSJulien Al ShakarchiWorcestershire Acute Hospitals NHS Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Khawaja et al. (2015) studied this question.

synapsesocial.com/papers/6a0aa7070830b72fa67390e4https://doi.org/10.1007/s13244-015-0420-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nephrogenic Systemic Fibrosis2012 · 118 citations
  2. 2Mechanism of NSF: New evidence challenging the prevailing theory2009 · 44 citations
  3. 3Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis2008 · 129 citations
  4. 4Risk of Nephrogenic Systemic Fibrosis: Evaluation of Gadolinium Chelate Contrast Agents at Four American Universities2008 · 187 citations
  5. 5Diagnostic Accuracy of Computer Tomography Angiography and Magnetic Resonance Angiography in the Stenosis Detection of Autologuous Hemodialysis Access: A Meta-Analysis2013 · 11 citations